Search clinical trials for: Angiotensin II Type 1 Receptor Blockers

Total 1992 results

Organon and Co

Completed

Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)

Hypertension
Radboud University Medical Center

Terminated

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Severe Acute Respiratory Syndrome | COVID-19 | COVID | Acute Respiratory Distress Syndrome | SARS-CoV-2

Netherlands
Yuhan Corporation

Completed

Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

Hypertension | Dyslipidemia

Korea, Republic of
Pharmtechnology LLC
Algorithme Pharma, An Altasciences Company

Completed

Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State

Bioequivalence

Canada
Takeda

Completed

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

Hypertension

Japan
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male Volunteers

Healthy
Novartis

Completed

Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise

Hypertension

Singapore, Hungary, Czech Republic, United Kingdom
Odense University Hospital
University of Southern Denmark; Lundbeck Foundation; Else Poulsen Mindelegat

Unknown

Prevention of Decompensation in Liver Cirrhosis

Ascites | Alcoholic Liver Cirrhosis

Denmark
Second Affiliated Hospital, School of Medicine,...

Recruiting

Azilsartan in Patients With Diabetic Kidney Disease and Hypertension

Diabetic Kidney Disease | Proteinuria | Blood Pressure | Kidney Dysfunction

China
Boehringer Ingelheim

Completed

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

Hypertension | Diabetic Nephropathies

Taiwan, United States, Canada, Thailand, Korea, Republic of, Argentina, Australia, Brazil, Mexico, New Zealand
University of Oxford

Completed

The Effect of Losartan on Emotional Processing in Healthy Volunteers

Healthy Volunteers
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Pediatric Hypertension With or Without CKD

Belgium, Poland, Italy, Germany, Guatemala, France, Hungary, Brazil, Lithuania
Takeda

Completed

Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"

Hypertension
Sanofi

Completed

AVE7688 in Patients With Mild to Moderate Blood Pressure (RAVEL-1)

Hypertension

United States, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Turkey, Malaysia, Singapore, Taiwan, Mexico, Argentina, Korea, Republic of, Chile, Hong Kong, South Africa, Greece
Boehringer Ingelheim

Completed

Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis (ESPRIT)

Hypertension
Institute for Clinical and Experimental Medicine
Ministry of Health, Czech Republic

Completed

Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes

Insulin Resistance | Type 2 Diabetes

Czech Republic
Novartis

Completed

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus (ViVID)

Hypertension

United States
Bayer

Completed

COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia (COUGH)

Hypertension

Slovakia
Daewoong Pharmaceutical Co. LTD.

Completed

A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

Healthy Volunteers

Korea, Republic of
Novartis

Completed

Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal (ASSERTIVE)

Hypertension

Brazil, Canada, Ecuador, Germany, Hungary, Korea, Republic of, Malaysia, Mexico, Panama, Philippines, Singapore, Slovakia, Spain, Turkey, United Kingdom, Venezuela
National Taiwan University Hospital

Unknown

Olmesartan on Ambulatory Blood Pressure Change

Hypertension

Taiwan
Shaheed Faghihi Hospital
Shiraz University of Medical Sciences

Completed

Effect of Turmeric on Diabetic Nephropathy

Diabetic Nephropathy | Proteinuria

Iran, Islamic Republic of
HK inno.N Corporation

Recruiting

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

Hypertension

Korea, Republic of
Anna Stanhewicz, PhD

Recruiting

Losartan for Improved Vascular Endothelial Function After Preeclampsia (LIVE-PE)

Preeclampsia Postpartum

United States
Daiichi Sankyo, Inc.

Completed

A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis

Atherosclerosis
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions

Hypertension

United States
University of South Florida
National Cancer Institute (NCI)

Withdrawn

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Lung Cancer | Dyspnea | Pulmonary Complications | Radiation Fibrosis
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI); Merck Sharp & Dohme LLC

Completed

Efficacy of Losartan in Preventing Progression of COPD

Smoking | Emphysema | COPD | Chronic Bronchitis

United States
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

Hypertension

Romania
Bayer

Completed

COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland (COUGH)

Hypertension

Poland
Kumamoto University
Japan Heart Foundation; The 4C trial bureau

Completed

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

Coronary Artery Disease | Hypertension

Japan
Medical University of Gdansk

Completed

The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria

Proteinuria | Chronic Kidney Disease
Baker Heart and Diabetes Institute

Unknown

The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension

Hypertension | Abdominal Obesity

Australia
Bayer
International Clinical Trials Association

Completed

Survey to Assess Why People Are Not Responding to Treatment in Hypertension

Arterial Hypertension

France
Daiichi Sankyo Co., Ltd.

Completed

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Type 2 Diabetes Mellitus | Diabetic Nephropathy | Proteinuria

Japan, China
Pfizer

Completed

Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide

Hypertension
Instituto Nacional de Ciencias Medicas y Nutricion...
National Council of Science and Technology, Mexico

Unknown

Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis

Atherosclerosis | Lupus Nephritis

Mexico
Kyoto University, Graduate School of Medicine

Completed

Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)

Hypertension | Obstructive Sleep Apnea

Japan
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Terminated

Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? (ARBs CORONA II)

Covid19 | SARS-CoV Infection

Canada, France
Hospital Universitario Pedro Ernesto

Completed

Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine (CONTROL)

Hypertension | Diabetes Mellitus

Brazil
Hennepin Healthcare Research Institute

Completed

Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial (LIFE-HIV)

Fibrosis | Inflammation

United States
R-Pharm
Covance; Boryung Pharmaceutical Co., Ltd

Completed

Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension

Arterial Hypertension

Russian Federation
Daiichi Sankyo Co., Ltd.

Completed

Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

Essential Hypertension

Japan
Emory University

Completed

Losartan for Sickle Cell Kidney Disease (SCD-Losartan)

Sickle Cell Disease

United States
PD Dr. Grégoire Wuerzner
Swiss National Science Foundation

Completed

Renal Response to Lower Body Negative Pressure in Pre-hypertensive States

Hypertension | Obesity | White Coat Hypertension | Resistant Hypertension

Switzerland
Emory University

Completed

Effect of Valsartan on Carotid Artery Disease

Atherosclerosis | Carotid Artery Diseases

United States
Boehringer Ingelheim

Completed

Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers

Healthy
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Daiichi Sankyo, Inc.

Completed

Olmesartan Pediatric Pharmacokinetic (PK) Study

Hypertension

United States

3

Subscribe